E The 3-year OS rates in ESCC patients with IgA < 56.56 EU (n = 62) and IgA > 56.56 EU (n = 16) were 34.52% and 0, respectively, in lymph node metastasis (P = 0.092). This evidence concerns the gene CD79A and esophageal squamous cell carcinoma.